When a Lung Cancer Diagnosis Brings About a New Mission

Publication
Article
Lung Cancer Heroes®CURE® Lung Cancer Heroes® 2021 Essay Book
Volume 2

After receiving an advanced non-small cell lung cancer diagnosis, a competitive runner and cyclist began running toward a new goal: becoming a lung cancer advocate.

Frank was blessed to be very healthy his whole life. He has been a lifelong avid and competitive runner, cyclist and triathlete, placing in the top of his age group in numerous races including the U.S. Cycling Federation State Master’s Time Trial Cycling Championship. He is also an accomplished portrait and landscape artist.

From left: Theresa Zotto Noll and Frank Noll. Photo by Ben Hider.

From left: Theresa Zotto Noll and Frank Noll. Photo by Ben Hider.

Almost seven years ago, at age 62, Frank received a diagnosis of advanced non-small cell lung cancer. Even though the initial diagnosis and treatment, including chemotherapy, immuno- therapy, radiation and surgery to remove half of one lung, were difficult, he has used his experience with this disease to become a knowledgeable and ardent lung cancer awareness advocate.

Frank has raised more than $16,000 for lung cancer research at walk/run events and through an exhibit and sale of his art. He has been a guest and speaker at lung cancer conferences and has met with members of Congress at the Capitol to advocate for funding for research and early lung cancer screening. He is also a lifeline mentor for patients with newly diagnosed lung cancer at LUNGevity Foundation, a nonprofit lung cancer advocacy and support organization. In addition, he is involved in providing feedback to several pharmaceutical companies regarding literature and information provided to patients with lung cancer. His lung cancer story and his advocacy have been featured in several print and online publications.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jennifer King from the GO2 Foundation for Lung Cancer in an interview with CURE